"GABA Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
| Descriptor ID |
D018682
|
| MeSH Number(s) |
D27.505.519.625.240 D27.505.696.577.240
|
| Concept/Terms |
GABA Agents- GABA Agents
- Agents, GABA
- gamma-Aminobutyric Acid Agents
- Acid Agents, gamma-Aminobutyric
- Agents, gamma-Aminobutyric Acid
- gamma Aminobutyric Acid Agents
- GABAergic Agent
- Agent, GABAergic
- GABAergic Agents
- Agents, GABAergic
GABA Effect- GABA Effect
- Effect, GABA
- GABAergic Effect
- Effect, GABAergic
- GABAergic Effects
- Effects, GABAergic
- GABA Effects
- Effects, GABA
|
Below are MeSH descriptors whose meaning is more general than "GABA Agents".
Below are MeSH descriptors whose meaning is more specific than "GABA Agents".
This graph shows the total number of publications written about "GABA Agents" by people in this website by year, and whether "GABA Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "GABA Agents" by people in Profiles.
-
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis. Tremor Other Hyperkinet Mov (N Y). 2021 02 10; 11:7.
-
Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation. J Headache Pain. 2018 Aug 14; 19(1):68.
-
D-limonene exhibits superior antihyperalgesic effects in a ß-cyclodextrin-complexed form in chronic musculoskeletal pain reducing Fos protein expression on spinal cord in mice. Neuroscience. 2017 09 01; 358:158-169.
-
Activity-dependent switch of GABAergic inhibition into glutamatergic excitation in astrocyte-neuron networks. Elife. 2016 12 24; 5.